Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Endo Health Walks the Neutral Path
Yahoo/Zacks
Saturday, July 7, 2012 - 11:55am
tags:
Endo Health Solutions
FDA OKs screening test for colon cancer drug
Yahoo/AP
Saturday, July 7, 2012 - 11:52am
tags:
Qiagen, Erbitux, colon cancer
Pfizer Inc (PFE): Today's Featured Drugs Loser
The Steet
Saturday, July 7, 2012 - 11:51am
tags:
Pfizer
Eli Lilly's Cymbalta Gets Longer Market Exclusivity
investors.com
Saturday, July 7, 2012 - 11:49am
tags:
Eli Lilly, Cymbalta, generics
Law Office of Brodsky & Smith, LLC Announces Investigation of Amylin Pharmaceuticals, Inc.
Yahoo/BusinessWire
Saturday, July 7, 2012 - 11:29am
tags:
Amylin, lawsuits
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing In AEterna Zentaris Inc. To Contact The Firm
Yahoo/CNW Group
Saturday, July 7, 2012 - 11:29am
tags:
Aeterna Zentaris, lawsuits
Spectrum Pharmaceuticals and Allos Therapeutics Announce Additional Extension of Tender Offer Period for Shares of Allos Therapeutics
Yahoo/BusinessWire
Saturday, July 7, 2012 - 11:28am
tags:
Spectrum Pharmaceuticals, Allos, M&A
Exclusive: Celgene mulls Human Genome Sciences bid - source
Reuters
Saturday, July 7, 2012 - 11:27am
tags:
Celgene, Human Genome Sciences, M&A
Vertex Pharmaceuticals (VRTX): Today's Featured Health Care Loser
The Steet
Saturday, July 7, 2012 - 11:26am
tags:
Vertex Pharmaceuticals
Incyte Corp Ltd (INCY): Today's Featured Health Care Winner
The Steet
Saturday, July 7, 2012 - 11:25am
tags:
Incyte
Chelsea shareholder urges co to explore options
Reuters
Saturday, July 7, 2012 - 11:24am
tags:
Chelsea Therapeutics
ShangPharma Surges Most In 10 Months On Acquisition Offer
Bloomberg
Saturday, July 7, 2012 - 11:23am
tags:
ShangPharma, M&A
XOMA Enrolls for Gevokizumab Trials
Yahoo/Zacks
Saturday, July 7, 2012 - 11:22am
tags:
Xoma, gevokizumab, uveitis
Amylin Deal Signals Diabetes Space is Hot
Motley Fool
Friday, July 6, 2012 - 7:34pm
tags:
diabetes, Amylin, M&A, Bristol-Myers Squibb, AstraZeneca
Bristol-Myers Gets U.S. Approval For Wider Erbitux Use
Bloomberg
Friday, July 6, 2012 - 7:21pm
tags:
Bristol-Myers Squibb, colorectal cancer, Eli Lilly, Erbitux
Pfizer sued by retailers for generic Lipitor delay
Reuters
Friday, July 6, 2012 - 12:53pm
tags:
generics, Lipitor, Pfizer
U.S. court denies Sequenom's motion against Ariosa
Reuters
Friday, July 6, 2012 - 12:50pm
tags:
Ariosa, Sequenom, MaterniT21
How to Tell When A Drug Company Fibs About Clinical Trial Results
TheStreet.com
Friday, July 6, 2012 - 12:49pm
tags:
Osiris, clinical trials
Why the Street Should Love ViroPharma's Earnings
Motley Fool
Friday, July 6, 2012 - 12:47pm
tags:
ViroPharma, earnings
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Friday, July 6, 2012 - 12:46pm
tags:
Xoma, Vertex

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.